Arthur C. Butcher - 02 May 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP& Grp Pres, MedSurg & APAC
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 02 May 2023
Net transactions value: -$49,303
Form type: 4
Filing time: 03 May 2023, 16:56:36 UTC
Previous filing: 24 Mar 2023
Next filing: 22 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2,101	+9.1%	$0.000000	25,082	02 May 2023	Direct	F1
transaction	BSX	Common Stock	Tax liability	$49,303	-932	-3.7%	$52.90	24,150	02 May 2023	Direct
holding	BSX	Common Stock						2,545	02 May 2023	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-2,101	-25%	$0.000000	6,306	02 May 2023	Common Stock	2,101		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.